{"id":7549,"date":"2024-11-28T06:30:00","date_gmt":"2024-11-28T11:30:00","guid":{"rendered":"https:\/\/stillcoviding.ca\/en\/?p=7549"},"modified":"2024-11-28T16:13:47","modified_gmt":"2024-11-28T21:13:47","slug":"lets-put-montreals-idle-pharmaceutical-plant-to-good-use","status":"publish","type":"post","link":"https:\/\/stillcoviding.ca\/en\/news\/lets-put-montreals-idle-pharmaceutical-plant-to-good-use\/","title":{"rendered":"Let\u2019s put Montreal\u2019s idle pharmaceutical plant to good use"},"content":{"rendered":"

When COVID-19 first struck, Canada had a problem: It lacked domestic capacity to manufacture vaccines. Today, the government of Canada faces the opposite problem: It owns a factory that isn\u2019t manufacturing vaccines.<\/p>\n

The Biologics Manufacturing Centre (BMC) in Montreal was completed in 2021 at the cost of $126 million, and fully licensed by Health Canada in 2022. However, a 2021 deal with Novavax to produce their COVID-19 vaccine looks increasingly unlikely to produce a single dose. Indeed, despite annual operating costs around $17 million a year, the BMC has never produced anything.<\/p>\n","protected":false},"excerpt":{"rendered":"

When COVID-19 first struck, Canada had a problem: It lacked domestic capacity to manufacture vaccines. Today, the government of Canada faces the opposite problem: It owns a factory that isn\u2019t manufacturing vaccines.<\/p>\n

The Biologics Manufacturing Centre (BMC) in Montreal was completed in 2021 at the cost of $126 million, and fully licensed by Health Canada in 2022. However, a 2021 deal with Novavax to produce their COVID-19 vaccine looks increasingly unlikely to produce a single dose. Indeed, despite annual operating costs around $17 million a year, the BMC has never produced anything.<\/p>\n

Continue readingLet\u2019s put Montreal\u2019s idle pharmaceutical plant to good use<\/span><\/a><\/div>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[1240,96,18,21,178,1104,254,70,14,1059,15],"class_list":["post-7549","post","type-post","status-publish","format-standard","hentry","category-news","tag-biologics-manufacturing-centre","tag-canada","tag-covid-19","tag-health-canada","tag-montreal","tag-national-research-council-canada","tag-novavax","tag-quebec","tag-sars-cov-2","tag-tiohtiake","tag-vaccines","entry"],"_links":{"self":[{"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/posts\/7549","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/comments?post=7549"}],"version-history":[{"count":2,"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/posts\/7549\/revisions"}],"predecessor-version":[{"id":7551,"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/posts\/7549\/revisions\/7551"}],"wp:attachment":[{"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/media?parent=7549"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/categories?post=7549"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/tags?post=7549"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}